United States & Canadian Academy of Pathology

USCAP 114th Annual Meeting

March 22-27, 2025 | Boston, MA

Ibex_PV1

Visit Ibex at booth #929!

Stop by booth #929 and learn why Ibex is the most widely deployed AI platform in pathology. Our team of experts will demonstrate how AI insights can help improve the quality and speed of diagnosis in a series of breast, prostate and gastric cases.  

Schedule a demo
Discover more by exploring the latest Ibex clinical studies being presented at USCAP 2025.

Speaking Symposiums

  • AI in Primary Diagnosis: from FDA Clearance to Application in Real-World Settings

    Lunch symposium moderated by: Manuela Vecsler, PhD, VP Clinical and Scientific Affairs at Ibex

    Monday | March 24 | 12:00 - 1pm

    Exhibitor Seminar Room 3

    • Mahul Amin, MD

      Mahul Amin, MD Labcorp & University of Tennessee

    • Harsh Thaker, MD, PhD

      Harsh Thaker, MD, PhD University of Texas Medical Branch

    • Mariano de Socarraz

      Mariano de Socarraz CorePlus

  • Differentiation Between HER2 Ultra-low and HER2 Null Breast Cancers Using an AI Support Tool: A Multi-Site Study

    Breast Pathology Platform

    Monday | March 24 | 1 - 2:30 pm

    BCEC Ballroom (Level 3)

    • Elena Provenzano, MD

      Elena Provenzano, MD Cambridge University Hospitals NHS Foundation Trust

Poster Presentations

  • Triage and Diagnosis of Primary Gastric Carcinoma Using an AI Solution: A Real-World Pilot Study in Japan

    Partners: Kameda Medical Center 

    Presenters: Kris Lami, MD, PhD

    Tuesday | March 25 | 1 - 4:30pm

    Board #98

  • Artificial Intelligence-assisted Diagnosis of Breast Lesions Shows Improved Accuracy and Efficiency on Histologic Slides

    Partner: The Ohio State University

    Presenters: Maryam Tahir, MD

     

    Tuesday | March 25 | 1 - 4:30pm

    Board #3

Learn why pathologists choose Ibex as their trusted AI partner.

  • Alverno Laboratories serves over 30 hospital laboratories and thousands of physician offices and other care facilities, touching over 8 million patients’ lives per year across the Midwest. They have partnered with Ibex and are now using AI-powered digital pathology in routine practice. In this video, CEO Sam Terese and team explain their digital workflow, the benefits AI brings to cancer diagnostics and patient care, and why they chose to work with Ibex.
  • Dr. Dimitrios Korentzelos (UPMC) discusses the routine use of Ibex Prostate AI for primary diagnosis of prostate biopsies in clinical practice. He presents data that demonstrates the solution’s effectiveness in improving diagnostic precision, reducing cancer misdiagnosis rates and enhancing workflow efficiency in digital pathology.